Zydus Pharmaceuticals (USA) Inc., the U.S. generic drug branch of Zydus Lifesciences, experienced unauthorized activity on its computer network on or around July 28, 2024. Following an investigation, Zydus determined that a data breach may have compro...
We've done the analysis so you can make the decisions
Search our repository of 8,564 high-quality, objective, peer-reviewed case studies, impacting 8,576 companies and resulting in $49,333,562,270 in net costs